Startups Directory

We created an AI-powered mobile app that helps to reduce domestic food waste and optimize cooking and groceries through predictive algorithms, and increase accessibility to professional nutrition advice by connecting users to diet professionals.

We created an AI-powered mobile app that helps to reduce domestic food waste and optimize cooking and groceries through predictive algorithms, and increase accessibility to professional nutrition advice by connecting users to diet professionals.

by reducing the decision fatigue for home cooks, we bring back the joy of cooking, allowing for a better control over one's diet. Combined with predictive capabilities, the software will create a major positive impact on overall health and food waste rends.

€170k

€330k

Born in 2023 with the mission to bring Intara to the Market. Intara is the first automátically regulates inflation device for Angioplasty providing safety and reproducibility to the procedures, like never before

Born in 2023 with the mission to bring Intara to the Market. Intara is the first automátically regulates inflation device for Angioplasty providing safety and reproducibility to the procedures, like never before

Intara with all the advances achieved in the last 2 decades, is going to reduce or eliminate vascular related major amputation in the decade 2040-50. Additionally both intrahospitalary and extrahospitalary costs will be drastically reduced or eliminated. Intara acts like a catalyst improving the results of any angioplasty regardless of the caractheristics of the lesion and the angioplasty device chosen ( balloon or the balloon mounted stent)

€500k

€700K

The METALS project transforms wasted low‑grade heat from industry, solar thermal systems, and data centers into clean energy functions. Leveraging advanced Metal–Organic Frameworks (MOFs) developed at Université PSL, the technology enables efficient heat storage, boosts thermal system performance, and delivers cooling solutions that consume up to 90% less electricity without harmful refrigerants. Validated by a 1 kWh demonstrator and backed by patents and publications, METALS offers scalable integration into industrial sites, buildings, and smart thermal grids—advancing energy efficiency and climate mitigation.

The METALS project transforms wasted low‑grade heat from industry, solar thermal systems, and data centers into clean energy functions. Leveraging advanced Metal–Organic Frameworks (MOFs) developed at Université PSL, the technology enables efficient heat storage, boosts thermal system performance, and delivers cooling solutions that consume up to 90% less electricity without harmful refrigerants. Validated by a 1 kWh demonstrator and backed by patents and publications, METALS offers scalable integration into industrial sites, buildings, and smart thermal grids—advancing energy efficiency and climate mitigation.

By harnessing advanced Metal–Organic Frameworks (MOFs) and water adsorption cycles, METALS captures and stores this latent thermal energy, converting it into useful functions such as clean cooling, efficient heat storage, and enhanced thermal system performance. In doing so, it reduces electricity consumption for cooling by up to 90%, eliminates harmful refrigerants, and enables scalable integration into industrial sites, buildings, and smart thermal grids—directly tackling energy inefficiency, rising cooling demand, and climate impact.

We are preparing a financing round scheduled for June 2026, with a target raise of €1.5 million.

€2 millions (including bpifrance subsidies)

Celentis is a biotechnology brand that specializes in converting advanced academic research into market-ready chemical and molecular sensors. Originating from a collaboration with the Interuniversity Institute for Research in Molecular Recognition and Technological Development (IDM), the company focuses on creating "smart materials" for personal safety and biomedical applications. Their portfolio primarily includes colorimetric systems designed to detect chemical submission drugs like GHB and scopolamine in beverages, as well as specialized sensors for identifying senescent cells to support anti-aging and age-related disease research.

Celentis is a biotechnology brand that specializes in converting advanced academic research into market-ready chemical and molecular sensors. Originating from a collaboration with the Interuniversity Institute for Research in Molecular Recognition and Technological Development (IDM), the company focuses on creating "smart materials" for personal safety and biomedical applications. Their portfolio primarily includes colorimetric systems designed to detect chemical submission drugs like GHB and scopolamine in beverages, as well as specialized sensors for identifying senescent cells to support anti-aging and age-related disease research.

Celentis empowers personal safety by providing accessible, real-time tools to detect "date-rape" drugs and prevent sexual violence. Ultimately, they transform complex chemistry into practical solutions that protect lives and extend human health.

€300.000

€300.000

Our team develops ultra-light, highly integrable antenna solutions designed specifically for new generation satellites. Building on advanced research in reflectarray and transmitarray technologies, we create flat, space-fed antennas that exceed the performance of traditional reflectors while drastically reducing mass, volume, and cost. Their engineered planar architecture allows precise control of the electromagnetic wave, enabling beam steering, shaped-beam coverage, and polarization conversion, without complex feed networks. A key strength of this technology is its thin, lightweight structure. These customizable antennas could be mounted, folded, or segmented alongside the satellite surfaces, enabling reduced time-to-space and efficient packaging for launch and large effective apertures once deployed. Combining panels with traditional phased array technology results in a hybrid architecture that allows for in-mission antenna behavior software reconfigurability, also their multiband potential allows multiple and secure communication services to be supported within a single compact structure even under jamming threats thanks to frequency hopping, enhancing mission versatility. In addition, the technology could integrate with other satellite subsystems, including co-deployment with solar panels, maximizing usable surface area without increasing satellite dimensions. We deliver high-performance, low-profile antenna solutions engineered for the realities of New Space, compact, scalable, cost-effective, and ready for integration. Our technology enables satellite developers to: • Boost communication capability without expanding spacecraft size, • Combine antennas and solar panels for optimal use of surface area, • Support multiband operation with a single lightweight structure, • Reduce system complexity, mass, and cost. • Accelerate mission development with reliable, space-ready designs. With strong expertise in electromagnetic engineering and a clear focus on real mission needs, we aim to equip the New Space community with antenna systems that deliver more performance, more flexibility, and more value, within the smallest possible footprint.

Our team develops ultra-light, highly integrable antenna solutions designed specifically for new generation satellites. Building on advanced research in reflectarray and transmitarray technologies, we create flat, space-fed antennas that exceed the performance of traditional reflectors while drastically reducing mass, volume, and cost. Their engineered planar architecture allows precise control of the electromagnetic wave, enabling beam steering, shaped-beam coverage, and polarization conversion, without complex feed networks. A key strength of this technology is its thin, lightweight structure. These customizable antennas could be mounted, folded, or segmented alongside the satellite surfaces, enabling reduced time-to-space and efficient packaging for launch and large effective apertures once deployed. Combining panels with traditional phased array technology results in a hybrid architecture that allows for in-mission antenna behavior software reconfigurability, also their multiband potential allows multiple and secure communication services to be supported within a single compact structure even under jamming threats thanks to frequency hopping, enhancing mission versatility. In addition, the technology could integrate with other satellite subsystems, including co-deployment with solar panels, maximizing usable surface area without increasing satellite dimensions. We deliver high-performance, low-profile antenna solutions engineered for the realities of New Space, compact, scalable, cost-effective, and ready for integration. Our technology enables satellite developers to: • Boost communication capability without expanding spacecraft size, • Combine antennas and solar panels for optimal use of surface area, • Support multiband operation with a single lightweight structure, • Reduce system complexity, mass, and cost. • Accelerate mission development with reliable, space-ready designs. With strong expertise in electromagnetic engineering and a clear focus on real mission needs, we aim to equip the New Space community with antenna systems that deliver more performance, more flexibility, and more value, within the smallest possible footprint.

By reducing the size, weight, and cost of satellite antennas while enhancing performance, we enable faster deployment of constellations that deliver global connectivity, Earth observation, and climate monitoring. This means more affordable broadband for underserved communities, quicker access to disaster response data, and improved tools for tracking environmental change. Moreover, the scalability and reduced risk of our design lower barriers for emerging space nations and startups, democratizing access to orbital capabilities.

€1.000.000

€1.000.000

TraffikGene is a spinoff company from Universidad de Santiago de Compostela developing a novel non-viral delivery platform for the next generation of nucleic acid therapeutics providing unique efficacy, safety and targeting features. We have secured more than 3.5 M euros in non dilutive funding (including EIC Pathfinder and EIC Transition).

TraffikGene is a spinoff company from Universidad de Santiago de Compostela developing a novel non-viral delivery platform for the next generation of nucleic acid therapeutics providing unique efficacy, safety and targeting features. We have secured more than 3.5 M euros in non dilutive funding (including EIC Pathfinder and EIC Transition).

What if we knew how to cure a disease but lacked the technical means to properly develop that solution? Nucleic acid therapeutics have the potential to revolutionize medicine because they target the genetic origin of diseases, providing precision and versatility. With the current delivery toolbox (LNPs, viral vectors, polymers) this promise is not fully realised because drug developers lack an efficient delivery toolbox for enhancing pharmacological properties and accessing the drug's target sites selectively. TraffikGene provides a highly enabling technology platform which will fulfill the current unmet needs of the RNA therapeutics field to engineer the next generation of advanced therapeutics, potentially helping millions of patients in need.

3.5 M euros

3.5 M euros

At Daphne Water Solutions, we are reimagining wastewater treatment through a living, nature-based technology built on the resilience of Daphnia, tiny water organisms brought back from the past. Our mission is to transform how we treat water—naturally, efficiently, and sustainably

At Daphne Water Solutions, we are reimagining wastewater treatment through a living, nature-based technology built on the resilience of Daphnia, tiny water organisms brought back from the past. Our mission is to transform how we treat water—naturally, efficiently, and sustainably

As water utilities, land managers, and industries face growing pressure to remove forever and persistent pollutants from wastewater, DWS provides a uniquely sustainable alternative to chemical- and energy-intensive treatment systems. Our solution operates with zero energy, zero chemicals, and virtually no land footprint, offering reuse-ready water while directly supporting regional net-zero targets. Independent Life Cycle Assessment shows the scale of our impact: 99.8% lower greenhouse-gas emissions, 0.29 m³ of water saved per m³ treated, up to 80% less waste, and a negligible land requirement, with remaining solids converted into biochar as part of a circular-economy model.

£1.5M

£3-4M

SISTAM is a Deeptech start-up currently developing, in collaboration with CSIC, a disruptive deep-inspection pilot for detecting pathologies in reinforced concrete structures at great depth, aimed at transforming maintenance and conservation practices for bridges and viaducts. This innovative system is non-invasive and enables smarter, rather than merely preventive, maintenance. With the technology at TRL 4, private investors are sought to reach the pilot stage. The project has received support from the Spanish Ministry of Science and Innovation (MICINN), Deeptech Madrid 2025 and the European Space Agency, among others.

SISTAM is a Deeptech start-up currently developing, in collaboration with CSIC, a disruptive deep-inspection pilot for detecting pathologies in reinforced concrete structures at great depth, aimed at transforming maintenance and conservation practices for bridges and viaducts. This innovative system is non-invasive and enables smarter, rather than merely preventive, maintenance. With the technology at TRL 4, private investors are sought to reach the pilot stage. The project has received support from the Spanish Ministry of Science and Innovation (MICINN), Deeptech Madrid 2025 and the European Space Agency, among others.

SISTAM will significantly enhance public safety by enabling early detection of hidden structural degradation in bridges and viaducts, reducing the risk of unexpected failures. Its non-invasive deep-inspection capability will help infrastructure owners optimize maintenance budgets, extend the lifespan of critical assets, and reduce CO₂ emissions associated with unnecessary repairs or premature reconstruction. By providing more reliable diagnostic data, the technology supports more sustainable, resilient, and cost-efficient management of civil infrastructure—ultimately benefiting citizens, governments, and industry.

€500.000

€1.650.000

Glotac Technologies is a materials-science startup specializing in the design and production of advanced aerogels. Using scalable, energy-efficient manufacturing based on microwave-assisted processing, we deliver high-purity, lightweight materials with precisely controlled porosity and composition. Our solutions enable high-performance materials for electrochemical devices and biosensors, as well as next-generation thermal insulation for maritime and industrial applications.

Glotac Technologies is a materials-science startup specializing in the design and production of advanced aerogels. Using scalable, energy-efficient manufacturing based on microwave-assisted processing, we deliver high-purity, lightweight materials with precisely controlled porosity and composition. Our solutions enable high-performance materials for electrochemical devices and biosensors, as well as next-generation thermal insulation for maritime and industrial applications.

Our technology will accelerate the transition to cleaner and more efficient energy systems by providing sustainable, high-performance materials for next-generation batteries and electrochemical devices. This enables lower-emission energy storage, longer-lasting devices, and reduced reliance on critical raw materials. By offering a scalable and low-carbon production route, it also supports circular-economy models and contributes directly to reducing the environmental footprint of energy technologies.

150.000 €

Currently we have not received any private investment, only grants.

We are a Contract Research Organization (CRO) specializing in preclinical studies, offering tailored solutions for biotech and pharmaceutical companies to support the development of new therapies.

We are a Contract Research Organization (CRO) specializing in preclinical studies, offering tailored solutions for biotech and pharmaceutical companies to support the development of new therapies.

Help to develop new drugs for different diseases

€0

€120.000

EvoPhase is a University of Birmingham spinout advancing industrial AI for complex process systems. The company applies evolutionary optimisation and high-fidelity simulation to improve energy efficiency, reduce waste, and increase throughput across sectors such as manufacturing, pharmaceuticals, and sustainable infrastructure.

EvoPhase is a University of Birmingham spinout advancing industrial AI for complex process systems. The company applies evolutionary optimisation and high-fidelity simulation to improve energy efficiency, reduce waste, and increase throughput across sectors such as manufacturing, pharmaceuticals, and sustainable infrastructure.

Our technology improves society by making heavy industry cleaner, more efficient and more resilient. By autonomously optimising complex process systems, it cuts energy use, emissions and raw material waste, directly supporting net zero and circular economy targets. This reduces operating costs and volatility in supply chains, helping keep essential products such as food, medicines and consumer goods affordable and available. At the same time, it augments rather than replaces engineers, embedding their expertise in validated digital models and freeing them from manual trial and error, which supports safer plants, better working conditions and higher value jobs in advanced manufacturing and process industries.

£1.200.000

£1.200.000

The start-up develops products that are designed to protect mucosal surfaces (found across the body) from infection or allergic response. The first products from the company (nasal and oral spray) are sold internationally and it is now looking to expand its product portfolio to include ocular protection.

The start-up develops products that are designed to protect mucosal surfaces (found across the body) from infection or allergic response. The first products from the company (nasal and oral spray) are sold internationally and it is now looking to expand its product portfolio to include ocular protection.

It will significantly improve the life experience of many people who suffer from infections and allergies. This is particularly important in places where high-levels of pollution are a problem.

£500k

£1m

Microplastics in our brain! Anymore. MekreoPolymer Biotechnology the unique solution to transform agricultural biomass into a smart biomaterial, compostable and active transformable into agricultural products. With modular design adaptable to current processes. The step forward in crop care and human health

Microplastics in our brain! Anymore. MekreoPolymer Biotechnology the unique solution to transform agricultural biomass into a smart biomaterial, compostable and active transformable into agricultural products. With modular design adaptable to current processes. The step forward in crop care and human health

Our solution is to transform this biomass into Mekreo Polymer. We offer a new bio technological solution to produce a compostable and active material that can be transform into agricultural products like crop film or phytosanitary bottles. In the use increases the carbon and nutrients in the soil making it more fertile and at the end returns as new biomass doing a complete circular system. A modular technology that generates radical increases in revenues and avoiding microplastics and increasing the productivity of the crops and improving human health. We will avoid and capture more than 1 million Tn of CO2 emissions in seven years. The first intelligent material from and for the agriculture sustainability.

€450.000

€450.000

Development of innovative antidotes against neurotoxic nerve agents poisoning (chemical warefare agents and pesticides)

Development of innovative antidotes against neurotoxic nerve agents poisoning (chemical warefare agents and pesticides)

Address threat (chemical weapon)

€3000K

€15 millions

Augura Space is building next-generation space weather intelligence services using advanced AI models. We provide real-time monitoring, actionable forecasts and anomaly diagnostics to help operators in space and aviation better manage radiation, ionospheric disturbances and environmental risks. Founded by experts in space physics and AI, the company transforms scientific research into operational resilience.

Augura Space is building next-generation space weather intelligence services using advanced AI models. We provide real-time monitoring, actionable forecasts and anomaly diagnostics to help operators in space and aviation better manage radiation, ionospheric disturbances and environmental risks. Founded by experts in space physics and AI, the company transforms scientific research into operational resilience.

Space-weather events generate costly disruptions across aerospace, telecommunications, energy and transportation. Our AI-based forecasts and monitoring tools help organisations anticipate these risks, limit operational losses, and optimise decision-making. This contributes to more reliable infrastructure and lowers the economic impact of solar storms on society.

1,5M€

1.5M€